(Q53919103)

22 May 2018

title

In vitro and in vivo activity of an antibacterial peptide analog against uropathogens. (English)

1 reference

22 May 2018

author name string

Mare Cudic

1

1 reference

22 May 2018

C Virginia Lockatell

2

1 reference

22 May 2018

David E Johnson

3

1 reference

22 May 2018

Laszlo Otvos

4

1 reference

22 May 2018

publication date

1 June 2003

1 reference

22 May 2018

number of pages

14

1 reference

inferred from page(s)

published in

Peptides

1 reference

22 May 2018

volume

24

1 reference

22 May 2018

issue

6

1 reference

22 May 2018

page(s)

807-820

1 reference

22 May 2018

Enlarged scale chemical synthesis and range of activity of drosocin, an O-glycosylated antibacterial peptide of Drosophila.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Design of a potent combined pseudopeptide endothelin-A/endothelin-B receptor antagonist, Ac-DBhg16-Leu-Asp-Ile-[NMe]Ile-Trp21 (PD 156252): examination of its pharmacokinetic and spectral properties

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

The influence of peptide structure on transport across Caco-2 cells. II. Peptide bond modification which results in improved permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Development of novel antibacterial peptides that kill resistant isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Emergence of ciprofloxacin resistance in Escherichia coli isolates after widespread use of fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Innovative strategies for the oral delivery of drugs and peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Fluoroquinolones in the treatment of acute uncomplicated urinary tract infections in adult women

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Pro-rich antimicrobial peptides from animals: structure, biological functions and mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

In vitro antibacterial properties of pexiganan, an analog of magainin

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing beta-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Inhibition of transglycosylation involved in bacterial peptidoglycan synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Cationic antimicrobial peptides: towards clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Cationic peptides: a new source of antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Range of activity and metabolic stability of synthetic antibacterial glycopeptides from insects.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Emerging mechanisms of fluoroquinolone resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Discovery of disseminated J96-like strains of uropathogenic Escherichia coli O4:H5 containing genes for both PapG(J96) (class I) and PrsG(J96) (class III) Gal(alpha1-4)Gal-binding adhesins

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Resistance patterns among nosocomial pathogens: trends over the past few years

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Delivery systems for penetration enhancement of peptide and protein drugs: design considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Detection of beta-lactamase-mediated resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

In vitro activity of clinafloxacin against fluoroquinolone resistant Spanish clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Rapid gentamicin bioassay using a multiple-antibiotic-resistant strain of Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Radiolabelled antimicrobial peptides for infection detection.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Antibacterial properties of dermaseptin S4 derivatives with in vivo activity

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Insect peptides with improved protease-resistance protect mice against bacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

How do bacteria resist human antimicrobial peptides?

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Characterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Resistance studies with daptomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Colonization of skilled-care facility residents with antimicrobial-resistant pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

In-vitro selection of resistance of Staphylococcus aureus to teicoplanin and vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Lipid, sugar and liposaccharide based delivery systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Antibacterial system generated by lactoferrin in mice in vivo is primarily a killing system

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900172-4

7 January 2021

10.1016/S0196-9781(03)00172-4

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018